Muscular dystrophy
Conditions
Interventions
None listed
Sponsors
The University of Tokyo
National Hospital Organization (NHO) Hakone National Hospital
NHO Shimoshizu National Hospital
NHO Sendainishitaga National Hospital
NHO Hiroshimanishi Medical Center, NHO Iou National Hospital, NHO Akita National Hospital, NHO Aomori National Hospital,NHO Hokkaido Medical Center, NHO Kumamoto Saishun Medical Center, and NHO Suzuka Hospital.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with muscular dystrophy.
Exclusion criteria
Exclusion criteria: Patients without definitive diagnosis. Patients' refusal to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence, death, heart failure, arrhythmia, thromboembolism, hospitalization, speckle tracking strain imaging, cardiac enzymes and markers. | — |
Secondary
| Measure | Time frame |
|---|---|
| Renal failure, stroke, activities of daily life, quality of life. | — |
Countries
Japan
Contacts
Public ContactKoichi KIMURA
The University of Tokyo The Institute of Medical Science
Outcome results
None listed